newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported that on July 24, 2023, AgeX issued to Juvenescence Limited 211,600 shares of a